Chandler Robinson, CLP board member and Northwestern chemistry and math undergraduate, started a biotech company to develop a potentially life-saving drug, choline tetrathiomolybdate, for use in the treatment of Wilson’s Disease. That drug is nowin Phase III trials and has been acquired by a major company. “It was Chandler’s experience in doing research with Professor [Thomas] O’Halloran while an undergraduate that was to have a huge impact on his future career.”

Read the story>